UBS Confirms Buy Rating for Aviva (AIVAF)

Written by Emily J. Thompson, Senior Investment Analyst

Source: NASDAQ.COM

Updated: Nov 08 2025

0mins

Source: NASDAQ.COM

UBS Coverage and Price Target: UBS has reiterated a Buy recommendation for Aviva (OTCPK:AIVAF) with an average one-year price target of $8.99/share, indicating a potential upside of 49.14% from its current price of $6.03/share.
Projected Revenue and EPS: Aviva's projected annual revenue is estimated at $23,931 million, reflecting a decrease of 1.36%, with a projected non-GAAP EPS of 0.64.
Fund Sentiment: There are currently 310 funds reporting positions in Aviva, with a 2.31% increase in ownership over the last quarter, and total shares owned by institutions rose by 10.84% to 558,397K shares.
Shareholder Activity: Notable increases in share ownership were reported by several funds, including CAPITAL WORLD GROWTH & INCOME FUND, which increased its holdings by 91.09%, and EUROPACIFIC GROWTH FUND, which raised its allocation by 58.69% over the last quarter.

About the author

Emily J. Thompson

Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.